| Price | 43.00 |
| Price Change Today | 0.00 (0.00%) |
| P&P rating | ![]() |
| Zacks Rank | 2 - BUY |
| Open Price | $0.00 |
| Previous Close | $43.00 |
| Daily Range | $0.00 - $0.00 |
| 52-Week Range | $31.30 - $44.09 |
| Volume | 0 |
| CVS/Caremark is the nation's premier integrated pharmacy services provider, combining one of the nation's leading pharmaceutical services companies with the country's largest pharmacy chain. The company fills or manages more than one billion prescriptions per year, more than any other pharmacy services provider. CVS/Caremark drives value for pharmacy services customers by effectively managing pharmaceutical costs and improving healthcare outcomes through its six thousand two hundred CVS/pharmacy stores; its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. | |





Comments: 0 | Comment
Why? ... Smiling ... the silver lining in every cloud ...
This Euro meltdown is a GREAT opportunity for USA companies, doing business in the EU with euros in their EU bank accounts, to profit from the meltdown by exchanging their euros for USA dollars. Therefore, I expect to see companies like MSFT and HPQ to report currency exchange rate GAINS in addition to product profits.
What tells me they're doing that ... when you exchange euros for the USD you are "selling" Euros ... and "buying" USD. The selling in Euros ... is driving the Euros down ... and the apparent availability of the euro to exchange for the USD signals lack of euro demand ... while the raising USD signals strong demand and lack of availability ... which the USA tried to head off at the pass by opening up the window to the EU. Seems the gov'ts were aware this scenario was coming ... and points for being ahead of the curve ... or this would be WORSE.
Surprise profits, and stocks "On sale, NOW!" ... that's why I'm bullish.
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment